BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Pseudomonas infection
,
Liver
,
Early pregnancy factor
,
Trichostatin A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glutamate carboxypeptidase ii human
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for glutamate carboxypeptidase ii human
Explore Curated Studies Results
Literature
Most Relevant Literature
Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
Antitumor immune response induced by DNA vaccine encoding human prostate-specific membrane antigen a…
Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimeti…
Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phos…
Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep).
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Assessing Colonic Folate Absorption & Metabolism
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ